vs
NETSTREIT Corp.（NTST）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是NETSTREIT Corp.的1.2倍（$69.8M vs $57.1M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs 10.0%，领先374.0%），NETSTREIT Corp.同比增速更快（24.3% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 20.1%）
NETSTREIT Corp.是一家总部位于美国的房地产投资信托（REIT），专注于收购和运营多元化的单租户净租赁商业物业组合，资产涵盖零售、工业、办公类别，主要服务于美国市场的投资级企业租户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
NTST vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.2倍
$57.1M
营收增速更快
NTST
高出3.1%
21.2%
净利率更高
RIGL
高出374.0%
10.0%
两年增速更快
RIGL
近两年复合增速
20.1%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $57.1M | $69.8M |
| 净利润 | $5.7M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 34.1% | 33.2% |
| 净利率 | 10.0% | 384.0% |
| 营收同比 | 24.3% | 21.2% |
| 净利润同比 | 235.9% | 1769.2% |
| 每股收益（稀释后） | $0.32 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收NTSTRIGL
| Q1 26 | $57.1M | — | ||
| Q4 25 | $52.5M | $69.8M | ||
| Q3 25 | $48.3M | $69.5M | ||
| Q2 25 | $48.3M | $101.7M | ||
| Q1 25 | $45.9M | $53.3M | ||
| Q4 24 | $44.1M | $57.6M | ||
| Q3 24 | $41.4M | $55.3M | ||
| Q2 24 | $39.6M | $36.8M |
净利润NTSTRIGL
| Q1 26 | $5.7M | — | ||
| Q4 25 | $1.3M | $268.1M | ||
| Q3 25 | $618.0K | $27.9M | ||
| Q2 25 | $3.3M | $59.6M | ||
| Q1 25 | $1.7M | $11.4M | ||
| Q4 24 | $-5.4M | $14.3M | ||
| Q3 24 | $-5.3M | $12.4M | ||
| Q2 24 | $-2.3M | $-1.0M |
毛利率NTSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% |
营业利润率NTSTRIGL
| Q1 26 | 34.1% | — | ||
| Q4 25 | 2.6% | 33.2% | ||
| Q3 25 | 1.3% | 40.9% | ||
| Q2 25 | 6.8% | 60.1% | ||
| Q1 25 | 3.7% | 23.9% | ||
| Q4 24 | -12.3% | 28.9% | ||
| Q3 24 | -12.8% | 25.4% | ||
| Q2 24 | -5.8% | 1.2% |
净利率NTSTRIGL
| Q1 26 | 10.0% | — | ||
| Q4 25 | 2.5% | 384.0% | ||
| Q3 25 | 1.3% | 40.2% | ||
| Q2 25 | 6.8% | 58.6% | ||
| Q1 25 | 3.7% | 21.5% | ||
| Q4 24 | -12.3% | 24.9% | ||
| Q3 24 | -12.8% | 22.5% | ||
| Q2 24 | -5.8% | -2.8% |
每股收益（稀释后）NTSTRIGL
| Q1 26 | $0.32 | — | ||
| Q4 25 | $0.01 | $14.11 | ||
| Q3 25 | $0.01 | $1.46 | ||
| Q2 25 | $0.04 | $3.28 | ||
| Q1 25 | $0.02 | $0.63 | ||
| Q4 24 | $-0.07 | $0.82 | ||
| Q3 24 | $-0.07 | $0.70 | ||
| Q2 24 | $-0.03 | $-0.06 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.5B | $391.5M |
| 总资产 | $2.8B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资NTSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M |
总债务NTSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | $1.1B | $52.5M | ||
| Q3 25 | $1.1B | $60.0M | ||
| Q2 25 | $926.6M | $60.0M | ||
| Q1 25 | $913.3M | $60.0M | ||
| Q4 24 | $868.3M | $60.0M | ||
| Q3 24 | $778.7M | $60.0M | ||
| Q2 24 | $726.2M | $60.0M |
股东权益NTSTRIGL
| Q1 26 | $1.5B | — | ||
| Q4 25 | $1.4B | $391.5M | ||
| Q3 25 | $1.3B | $117.6M | ||
| Q2 25 | $1.3B | $81.9M | ||
| Q1 25 | $1.3B | $18.6M | ||
| Q4 24 | $1.3B | $3.3M | ||
| Q3 24 | $1.3B | $-14.6M | ||
| Q2 24 | $1.3B | $-29.9M |
总资产NTSTRIGL
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.6B | $513.6M | ||
| Q3 25 | $2.5B | $242.5M | ||
| Q2 25 | $2.3B | $206.7M | ||
| Q1 25 | $2.3B | $176.0M | ||
| Q4 24 | $2.3B | $164.0M | ||
| Q3 24 | $2.2B | $139.4M | ||
| Q2 24 | $2.1B | $128.4M |
负债/权益比NTSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | 0.76× | 0.13× | ||
| Q3 25 | 0.84× | 0.51× | ||
| Q2 25 | 0.70× | 0.73× | ||
| Q1 25 | 0.70× | 3.23× | ||
| Q4 24 | 0.65× | 18.25× | ||
| Q3 24 | 0.58× | — | ||
| Q2 24 | 0.55× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流NTSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | $109.5M | $22.0M | ||
| Q3 25 | $28.0M | $24.0M | ||
| Q2 25 | $30.6M | $30.5M | ||
| Q1 25 | $22.1M | $-893.0K | ||
| Q4 24 | $90.2M | $14.5M | ||
| Q3 24 | $25.1M | $21.7M | ||
| Q2 24 | $25.4M | $302.0K |
现金转化率NTSTRIGL
| Q1 26 | — | — | ||
| Q4 25 | 82.46× | 0.08× | ||
| Q3 25 | 45.27× | 0.86× | ||
| Q2 25 | 9.36× | 0.51× | ||
| Q1 25 | 13.06× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
NTST
| Rental revenue (including reimbursable) | $54.0M | 95% |
| Other | $3.0M | 5% |
RIGL
暂无分部数据
